Potawatomi Ventures and Waséyabek Development Company, LLC are pleased to announce a strategic investment in BAMF Health, the world’s first vertically integrated platform for intelligence-based precision medicine. Potawatomi Ventures is the economic development and income diversification business of the Forest County Potawatomi Community, and Waséyabek Development Company is a holding company managing the Nottawaseppi Huron Band of the Potawatomi’s non-gaming economic development activities. The two companies invested in BAMF Health independently, but they did share their respective views on BAMF’s goals and accomplishments, demonstrating how tribes can work together for the betterment of all. The two Potawatomi organizations are both committed to investing in the technology sector and supporting innovation.
Headquartered in Grand Rapids, Michigan, BAMF Health uses intelligence-based precision medicine to detect and treat cancer and other diseases and to conduct clinical trials for novel radiopharmaceuticals. The company’s overriding mission is to empower patients to become people again.
“Potawatomi Ventures is thrilled to partner with BAMF Health,” said Paul Hoesly, chief financial and strategy officer of Potawatomi Ventures. “Our investment reflects our confidence in their innovative solutions and their potential to transform healthcare. We are committed to supporting companies that make a positive impact on society, and BAMF Health aligns perfectly with our strategic vision.”
“When we invested in BAMF Health in 2021, we were impressed by their vision and cutting-edge technology,” said Deidra Mitchell, president and chief executive officer of Waséyabek. “Since then, BAMF has accelerated its growth while further enhancing its innovative technology. We remain impressed by the company’s leadership and performance, as it works to deliver better patient outcomes.”